Supply of Abiraterone and Novel Androgen Receptor Inhibitors

Pharmac, the New Zealand pharmaceutical management agency, is seeking proposals for the supply of abiraterone and novel androgen receptor inhibitors (nARIs) for the New Zealand market. The RFP includes schedules covering background, process, estimated market size, and standard terms. Suppliers must submit proposals via GETS by 13 August 2026, with enquiries due by 31 July 2026. An online supplier briefing will be held on 16 July 2026. The contract likely involves long-term supply agreements for subsidized pharmaceuticals.